mesalamine has been researched along with Lymphoma, Large B-Cell, Diffuse in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Lymphoma, Large B-Cell, Diffuse: Malignant lymphoma composed of large B lymphoid cells whose nuclear size can exceed normal macrophage nuclei, or more than twice the size of a normal lymphocyte. The pattern is predominantly diffuse. Most of these lymphomas represent the malignant counterpart of B-lymphocytes at midstage in the process of differentiation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koo, TH | 1 |
| Choi, WJ | 1 |
| Han, SH | 1 |
| Kim, SY | 1 |
| Lee, JH | 1 |
1 other study available for mesalamine and Lymphoma, Large B-Cell, Diffuse
| Article | Year |
|---|---|
[A Case of Small Bowel Diffuse Large B-cell Lymphoma Mimicking Crohn's Disease].
Topics: Aged; Antibodies; Antineoplastic Combined Chemotherapy Protocols; Capsule Endoscopy; Crohn Disease; | 2015 |